1. Scrip
  2. >>Therapy Areas
  3. >>Anticancer

O'Neill Review outlines five steps for immediate AMR relief

 
• By Lucie Ellis-Taitt

Five practical steps to address the global problem of antibiotic drug resistance have been outlined in a new paper published as part of the O'Neill Review, which was commissioned by UK Prime Minister David Cameron to come up with solutions.

Five practical steps to address the global problem of antibiotic drug resistance have been outlined in a new paper published as part of the O'Neill Review, which was commissioned by UK Prime Minister David Cameron to come up with solutions.

The review, headed by economist and former head of Goldman Sachs Asset Management Jim O'Neill, has identified where action can...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Anticancer

More from Therapy Areas

Investors Back Nuclidium’s Next-Gen Copper-Based Radiopharmaceuticals

 
• By Andrew McConaghie

The Swiss company believes its platform can make radiopharmaceuticals easier to produce and more accessible to patients.

Taiho’s Oral, Mutation-Agnostic DMD Candidate Misses Phase III Endpoint

 
• By Lisa Takagi

The oral, twice-daily candidate was expected to control decline in motor function in DMD patients regardless of their gene mutations.

ProKidney Pins Hopes On Accelerated Approval For Rilparencel

 
• By Alaric DeArment

After posting encouraging Phase II results, the company plans to meet with the US FDA about using data from an ongoing Phase III study for an accelerated approval.